SEC Filing Details

Document Details

Form
DRS
Filing Date
May 14, 2014
Document Date
May 14, 2014
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.